Hurricane Capital Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Hurricane Capital Advisors's BMY Position: Q3 2026 in Review
Hurricane Capital Advisors increased its Bristol-Myers Squibb (BMY) stake by 155% in Q3 2026, buying an estimated $411K and bringing the position to 10,700 shares worth $668K. The position accounts for 0.06% of the portfolio, ranked #212.
Hurricane Capital Advisors first reported a position in BMY in Q4 2023 and has held it in 12 quarters since. 2,561 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- Hurricane Capital Advisors held 10,700 shares of Bristol-Myers Squibb worth $668K as of Q3 2026.
- Hurricane Capital Advisors bought 6,500 Bristol-Myers Squibb shares in Q3 2026, an estimated $411K.
- Bristol-Myers Squibb made up 0.06% of Hurricane Capital Advisors's portfolio in Q3 2026, its #212 holding.
- Hurricane Capital Advisors first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 12 quarters since.
- 2,561 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on Hurricane Capital Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.